Mod­er­na gets Au­to­lus tar­get­ing tech via li­cens­ing deal; Atai re­ports PhI da­ta for kratom-based ther­a­py

A year af­ter Au­to­lus Ther­a­peu­tics got it­self a part­ner in Mod­er­na via a li­cens­ing deal, Mod­er­na is ex­er­cis­ing its op­tion to ac­quire the biotech’s pro­pri­etary …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER